Elixirgen Therapeutics
Satoshi Kunitada, Ph.D., served as the Japanese head of clinical development at Daiichi Sankyo Co. Ltd (2010-2014) and as committee chairman of the Japan Pharmaceutical Manufacturers Association (2016-2020).
This person is not in the org chart
This person is not in any offices
Elixirgen Therapeutics
Elixirgen Therapeutics is a biotechnology company focused on curing humanity’s ailments through stem cell biology.